Simplexa Influenza A H1N1 (2009) Kit

Background

While the initial threat to world health has been alleviated, H1N1 is different from other flu A viruses and may challenge health care professionals and organizations for years to come. Which is why reliable detection by molecular testing continues to be extremely important especially for higher-risk patient populations.

Why to choose it

Quickly and accurately detect and differentiate H1N1 in your lab.

Benefits

Reliability

100% positive agreement for the H1N1 and influenza A virus.

AGREEMENT WITH COMPOSITE REFERENCE METHOD

2009 H1N1 CLINICAL AGREEMENT 

INFLUENZA A CLINICAL AGREEMENT 

Specimens were determined to be positive for 2009 H1N1 influenza by a composite reference method for the Flu A target including the Luminex xTAG RVP Flu A target, a validated PCR assay using primer and probe sequences published by the CDC and a well characterized PCR followed by sequencing.
Prospectively collected samples. 299 prospectively collected nasal/nasopharyngeal swabs and 112 nasopharyngeal aspirates were analyzed.

For use on

LIAISON MDX

Ordering Info

Please click below for more information

SIMPLEXA FLU A/B & RSV BROCHURE